"Radiopharmaceuticals" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)
| Descriptor ID |
D019275
|
| MeSH Number(s) |
D27.505.259.843 D27.505.519.871 D27.720.470.410.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Radiopharmaceuticals".
Below are MeSH descriptors whose meaning is more specific than "Radiopharmaceuticals".
This graph shows the total number of publications written about "Radiopharmaceuticals" by people in this website by year, and whether "Radiopharmaceuticals" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 2 | 3 |
| 2005 | 1 | 5 | 6 |
| 2006 | 0 | 5 | 5 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 3 | 4 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2014 | 1 | 2 | 3 |
| 2015 | 2 | 3 | 5 |
| 2016 | 2 | 5 | 7 |
| 2017 | 33 | 64 | 97 |
| 2018 | 28 | 52 | 80 |
| 2019 | 12 | 33 | 45 |
| 2020 | 3 | 5 | 8 |
| 2021 | 1 | 5 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Radiopharmaceuticals" by people in Profiles.
-
In Vivo Thrombosis Imaging in Patients Recovering from COVID-19 and Pulmonary Embolism. Am J Respir Crit Care Med. 2021 10 01; 204(7):855-856.
-
Imaging of Cardiac Infections: A Comprehensive Review and Investigation Flowchart for Diagnostic Workup. J Thorac Imaging. 2021 Sep 01; 36(5):W70-W88.
-
FDG PET/CT imaging features and clinical utility in COVID-19. Clin Imaging. 2021 Dec; 80:262-267.
-
18F-FDG-PET/CT in SARS-CoV-2 infection and its sequelae. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 Sep-Oct; 40(5):299-309.
-
Evolution of 18F-FDG PET/CT Findings in Patients After COVID-19: An Initial Investigation. J Nucl Med. 2022 02; 63(2):270-273.
-
FDG-Avid Ipsilateral Iliac and Inguinal Lymphadenopathy After COVID-19 Vaccination With Thigh Injection. AJR Am J Roentgenol. 2022 01; 218(1):180.
-
Effect of COVID-19 on 18F-FDG PET/CT: Is There a Need to Consider COVID-19 Status Before Planning 18F-FDG PET/CT for Oncologic Evaluation? J Nucl Med Technol. 2021 Sep; 49(3):284-285.
-
Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology? Eur J Nucl Med Mol Imaging. 2021 10; 48(11):3351-3352.
-
FDG-PET/CT of COVID-19 and Other Lung Infections. Semin Nucl Med. 2022 01; 52(1):61-70.
-
Incidental Findings Suggestive of COVID-19 Pneumonia in Oncologic Patients Undergoing 18F-FDG PET/CT Studies: Association Between Metabolic and Structural Lung Changes. J Nucl Med. 2022 02; 63(2):274-279.